PRESS RELEASE published on 05/03/2023 at 21:08, 1 year 6 months ago EQS-Adhoc: Brockhaus Technologies AG: Significant increase in revenue and adjusted EBITDA in Q1 2023 to €33.4 million and €9.6 million respectively (28.8% margin)
PRESS RELEASE published on 04/26/2023 at 18:41, 1 year 6 months ago Brockhaus Technologies AG: Subsidiary IHSE on course for profitable growth with record order situation in current fiscal year 2023
PRESS RELEASE published on 03/31/2023 at 07:05, 1 year 7 months ago Brockhaus Technologies AG: Brockhaus Technologies expects another record year for revenue and earnings in 2023
PRESS RELEASE published on 03/28/2023 at 08:01, 1 year 7 months ago EQS-Adhoc: Brockhaus Technologies AG: Brockhaus Technologies AG publishes forecast for fiscal year 2023
PRESS RELEASE published on 02/27/2023 at 20:06, 1 year 8 months ago EQS-Adhoc: Brockhaus Technologies AG: Forecast 2022 outperformed with preliminary results: revenue before PPA of €145m and adjusted EBITDA at €50m; adjusted EBITDA margin was 34.4%
PRESS RELEASE published on 02/15/2023 at 07:32, 1 year 9 months ago Brockhaus Technologies AG: Subsidiary Bikeleasing with record growth in 2022 and dynamic start in 2023
Published on 11/21/2024 at 13:30, 21 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 21 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 51 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 51 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 51 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 16 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 36 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 53 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 31 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 6 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 6 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
